SEC Filings

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
8-K 8-K 5/29/2020 5/29/2020
Abstract: On May 29, registrant announced that members of senior management will participate in the NAREIT REITWeek 2020 Investor Conference on June 2 and June 3.
8-K 8-K 5/11/2020 5/11/2020
Abstract: 8-K filed by National Health Investors Inc. (NHI) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 5/11/2020 5/11/2020
Abstract: 8-K filed by National Health Investors Inc. (NHI) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K 8-K 5/11/2020 5/11/2020
Abstract: 8-K filed by National Health Investors Inc. (NHI) covering Submission of Matters to a Vote of Security Holder and Regulation FD Disclosure.
10-Q 10-Q 5/11/2020 3/31/2020
Transcript AST 5/6/2020
Abstract: Transcript of National Health Investors, Inc. - Shareholder/Analyst Call
Transcript AST 5/6/2020
Abstract: Transcript of Transcript of National Health Investors, Inc. - Shareholder/Analyst Call on 5/6/2020
8-K 8-K 4/29/2020 4/29/2020
Abstract: On April 23, registrant announced dates of its first quarter financial results release and conference call.
8-K 8-K 4/22/2020 4/22/2020
Abstract: 8-K filed by National Health Investors Inc. (NHI) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Financial Statements and Exhibits.
Proxy DEFA14A 4/16/2020
8-K 8-K 4/3/2020 4/3/2020
Abstract: On April 3, registrant announced that senior management will be conducting virtual meetings with institutional investors as part of the Mizuho Inaugural Healthcare REIT Conference on April 7.
8-K 8-K 4/1/2020 4/1/2020
Abstract: 8-K filed by National Health Investors Inc. (NHI) covering Regulation FD Disclosure.
Financial Supplement FIN SUPP 3/31/2020
8-K 8-K 3/23/2020 3/23/2020
Abstract: On March 18, registrant announced that it provided update on Covid-19.
Proxy DEF 14A 3/20/2020 5/6/2020
8-K 8-K 3/19/2020 3/19/2020
Abstract: Registrant reported that it supplemented the risk factors set out in its annual report. The composite note purchase agreement was included by exhibit.
Registration Statement S-3ASR 3/19/2020
Abstract: Registrant filed a registration statement for an unspecified amount of certain types of securities. Proceeds from the offering will be used for general corporate purposes.
Prospectus 424B5 3/19/2020
8-K 8-K 3/13/2020 3/13/2020
Abstract: On March 10, registrant announced the details of its response to the evolving coronovirus (COVID-19) outbreak.
Proxy PRE 14A 3/10/2020 5/6/2020

Displaying 1 to 20 (of 237 filings)